-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905.P1.122 905. Outcomes Research—Lymphoid Malignancies: Poster I

Symposia: Outcomes Research—Lymphoid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Yoosun Lee1*, Junghyun Yoon, MPH2*, Boyoung Park, MD, PhD3* and Hyeon-Seok Eom, MD, PhD4*

1Medical Affairs, Janssen Korea, Seoul, Korea, Republic of (South)
2Department of Health Sciences, Hanyang University, Seoul, Korea, Republic of (South)
3Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Korea, Republic of (South)
4Department of Internal Medicine, Center for Hematologic Malignancy, National Cancer Center, Goyang-Si, Korea, Republic of (South)

Kaitlyn C Dykes, MD, BS1,2, Jiling Chou, MA3*, Allison Taylor, MD, MS4, MA Xiaoyang3* and Catherine Lai, MD, MPH5

1Department of Internal Medicine, MedStar Georgetown University Hospital, San Diego, CA
2UC San Diego Medical Center, San Diego, CA
3Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC, USA, Washington DC, DC
4Internal Medicine, Duke University School of Medicine, Durham
5Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA

Othman Salim Akhtar, MD1, Andrea Anampa-Guzman, MD1*, Matthew J Cortese, MD, MPH1, Alankrita Taneja, MBBS1, Sheeba Ba Aqeel, MD2, Paola Ghione, MD3, Francisco Hernandez-Ilizaliturri, MD4 and Pallawi Torka, MD1

1Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Department of Hematology and Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
3Roswell Park Comprehensive Cancer Center, New York, NY
4Roswell Park Cancer Institute, Buffalo, NY

Sumit Gupta, MD, PhD1,2,3, Qing Li, MSc4*, Paul Nathan, MD1,3,5*, Norma D'Agostino6*, Nancy N Baxter, MD, PhD7*, Colleen Fox, BSc, MSc8*, Natalie Coburn, MD9* and Rinku Sutradhar, PhD10*

1Cancer Research Program, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
2Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada
3Faculty of Medicine, University of Toronto, Toronto, ON, Canada
4Institute for Clinical Evaluative Sciences, Toronto, Canada
5Division of Haematology/Oncology, Hospital For Sick Children, Toronto, ON, Canada
6University Health Network, Toronto, Canada
7University of Melbourne, Melbourne, Australia
8Ontario Health, Toronto, ON, Canada
9Sunnybrook Hospital, Toronto, Canada
10Cancer Research Program, ICES, Toronto, ON, Canada

Lucía Castilla García1*, Sergio Ramos Cillán2*, Alberto Lopez García, MD2*, Natalia Barreras Ruiz3*, Eva Castillo Bazan3*, Adriana Pascual4*, Miriam Riesco Ovelar5*, Celia Urrutia5*, Susana Cruz6*, Alberto Pardo7*, Antonio Herrero8*, Maria Angeles Perez Saenz, MD9*, Daniel Morillo Gilles2*, María Pilar Llamas Sillero, MD, PhD10,11*, Javier Becares3*, Carla Barriocanal12*, Jorge Short Apellaniz12*, Marta del Olmo12*, Javier Arcos Campillo12* and Raul Cordoba, MD, PhD13

1Department of Hematology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain
2Fundación Jimenez Díaz University Hospital, Madrid, Spain
3Department of Pharmacy, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
4Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
5Oncohealth Institute, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
6Information and Communication technology (ICT) department., Fundación Jimenez Díaz University Hospital, Madrid, Spain
7Information and Communication technology (ICT) department., Fundacion Jimenez Diaz University Hospital, Madrid, Spain
8Information and Communication Technology (ICT) Department, Fundación Jiménez Díaz University Hospital, Madrid, Spain
9Haematology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, ESP
10Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
11Department of Hematology, Fundación Jiménez Díaz University Hospital, Madrid, Spain
12Clinical and Organizational Innovation Unit (UICO); QUIRONSALUD PUBLIC HOSPITALS NETWORK, Madrid, Spain
13Lymphoma Unit, Department of Hematology, Fundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain

Stefan K. Barta, MD1, Nicholas Liu, PharmD2*, Maral DerSarkissian, PhD3,4*, Rose Chang, MSPH, MS, ScD4*, Mingchen Ye, MS4*, Mei Sheng Duh, ScD, MPH4, Andy Surinach, MPH5*, Michelle A. Fanale, MD2 and Kristina S. Yu, PhD, MPH, RPh2*

1Perelman Center for Advanced Medicine, Philadelphia, PA
2Seagen Inc., Bothell, WA
3Analysis Group, Inc., Los Angeles, CA
4Analysis Group, Inc., Boston, MA
5Genesis Research, Hoboken, NJ

Ashley E. Rosko, MD1, Kaitlyn Dvorak, PhD2*, Qiuhong Zhao, MS1*, Electra Paskett3*, Samantha Jaglowski, MD, MPH4, James L. Fisher, PhD4*, Jessica Krok-Schoen5*, Francesca Cottini, MD6, Abdullah Khan, MBBS, MSc7, Srinivas Devarakonda, MD8, Naresh Bumma, MD9, Elvira Umyarova, MD10, Nidhi Sharma, PhD4*, Don M. Benson Jr., MD11 and Jesse Plascak, PhD12*

1Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
2The Ohio State Univeristy, Columbus, OH
3Division of Cancer Prevention and Control, Department of Internal Medicine, Coll, Columbus, OH
4The Ohio State University, Columbus, OH
5Ohio State University, Columbus, OH
6Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH
7Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH
8The Ohio State University Wexner Medical Center, Columbus, OH
9Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH
10Division of Hematology, The Ohio State University, Columbus, OH
11Riney Family Myeloma Center for Research Excellence, The Ohio State University Medical Center, Columbus, OH
12Division of Cancer Prevention and Control, The Ohio State University, Columbus, OH

Sheeba Ba Aqeel, MD1, Othman Salim Akhtar, MD1,2, Arya Mariam Roy, MBBS1, Alankrita Taneja, MBBS1, Richa Parikh, MD3, Muhammad Salman Faisal, MD, MBBS1, Hassan Awada, MD1*, Andrea Anampa-Guzman, MD1*, Matthew J Cortese, MD, MPH1, Francisco Hernandez-Ilizaliturri, MD1 and Pallawi Torka, MD1

1Roswell Park Comprehensive Cancer Center, Buffalo, NY
2Moffitt Cancer Center, Buffalo, NY
3Department of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI

Taiga Nishihori, MD1, Doris K. Hansen, MD1, Hien D. Liu, MD1, Omar Alexis Castaneda Puglianini, MD2, Ciara L. Freeman, MSc, FRCPath, MBBChir, MRCP2, Brandon J. Blue, MD3, Jason Brayer, MD, PhD4, Jongphil Kim, PhD5*, Ariel F Grajales-Cruz, MD4, Jose Ochoa, MD1, Rachid C. Baz, MD6, Kenneth H. Shain, MD, PhD4, Frederick L. Locke, MD7 and Melissa Alsina, MD**8

1Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
2Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
3Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
5Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institutte, Tampa, FL
6Department of Malignant Hematology, Moffitt cancer center and research institute, tampa, FL
7H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Moffitt Cancer Center, Tampa, FL

Naveen G Subramanian, MD1*, Fleur M. Aung, MD2, Krina Patel, MD, MSc3, Hans C. Lee, MD4, Shida Jin5*, Elliana Young, MS6* and Cristhiam Mauricio Rojas Hernandez, MD7

1Internal Medicine Residency, UTHealth McGovern Medical School, Austin, TX
2Department of Laboratory Medicine, Section of Transfusion Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma/Myeloma, UT MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
5Enterprise Integration & Development, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Enterprise Data Engineering & Analytics, The University of Texas MD Anderson Cancer Center, Houston, TX
7Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX

Audrey M. Sigmund, MD1, Michelle Fullmer, APRN-CNP1*, Rina Li, MPH1*, Tracelyn Freeman, PharmD, BCOP1*, Bryant Clemons, PharmD1*, Stefanie Quimjian, APRN-CNP1*, Heather Niccum Haag, BSN, RN, CCRN2*, Ai Ni, PhD3*, Shuiying Hu, PhD4*, Alice S. Mims, MD1, Gretchen A. McNally, PhD, ANP1*, Maryam Lustberg, MD5* and Bhavana Bhatnagar, DO6

1Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
2Division of Nursing, Department of Neuro-Oncology, The Ohio State University, Columbus, OH
3Department of Biostatistics, College of Public Health, The Ohio State University, Columbus, OH
4Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH
5Director Yale Breast Center, Comprehensive Yale Cancer Center, New Haven, CT
6Department of Hematology and Medical Oncology, West Virginia University Cancer Institute, Wheeling, WV

Ugochi Ebinama, MD1, Ajay Sheshadiri, MD2*, Sairah Ahmed, MD3, Hun Ju Lee, MD4, Meng Liu5* and Swaminathan Padmanabhan Iyer, MD6*

1University of Texas Health Sciences Center Houston, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas M D Anderson Cancer Center, Houston, TX
4University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Industrial Engineering, Penn State University, State College, PA, Philadelphia, PA
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Perla R. R. Colunga-Pedraza, MD1, Andres Gomez-De Leon, MD2, Christianne Bourlon De Los Rios, MD, MSc3, Cesar Omar Vargas-Serafin, MD4*, Myrna Patricia Pequeño Luevano, MD5*, Lauro Fabian Amador6*, Carolina García-Castillo, MD7*, Martha Alvarado, MD8*, Guillermo José Ruiz-Argüelles, MD, FRCP (Glasg), MACP, DSc(hc), FRCP9, Alberto Olaya-Vargas, MD; M.Sc10*, Samantha P. Peña-Lozano, MD11*, Guadalupe González Villarreal, MD12*, Elías Eugenio González López, MD13*, Gabriela Cardoso Yah14*, Ivan Murrieta-Alvarez, MD15*, Luis Mario Villela Martinez, MD, MSc16* and David Gomez Almaguer, MD17,18*

1Servicio de Hematología, Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario “Dr. José Eleuterio González”, Monterrey, NL, Mexico
2Universidad Autónoma de Nuevo León. Facultad de Medicina y Hospital Universitario Dr. José Eleuterio González., Monterrey, Mexico
3Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
4Department of Hematology and Oncology, Instituto Nacional De Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico
5Hematopoietic stem cell Unit IMSS UMAE 25, IMSS UMAE 25, Monterrey, MEX
6Hospital Regional de Alta Especialidad del Bajio, León, Mexico
7Hematología, Hospital Central Militar, SEDENA, Ciudad de México, Mexico
8Centro Medico Nacional 20 de Noviembre, Mexico City, Mexico
9Centro de Hematología y Medicina Interna, Clínica Ruiz, Puebla, PU, Mexico
10Division of Hematology/Oncology, Bone Marrow Transplant unit, National Pediatrics Institute, Ciudad de México, Mexico
11UniversidadUniversidad Autónoma de Nuevo León, Servicio de Hematología, Hospital Universitario “Dr. José E. González”, Monterrey, NL, Mexico
12Hematopoietic stem cell Unit IMSS UMAE 25, IMSS UMAE 25, Monterrey, NL, Mexico
13Escuela de Medicina y Ciencias de la Salud, Tec de Monterrey, Campus Monterrey, Monterrey, NL, Mexico
14Hospital Central Militar, SEDENA, Ciudad De Mexico, MEX
15Centro de Hematología y Medicina Interna de Puebla, Puebla, PU, Mexico
16Escuela de Medicina Del Tecnológico de Monterrey, Hermosillo, SO, Mexico
17Universidad Autónoma de Nuevo León, Servicio de Hematología, Hospital Universitario “Dr. José E. González”, Monterrey, NL, Mexico
18Gomez Almaguer Clinica de Hematologia, Monterrey, Mexico

Meredith Jackson1*, Heather Reves, MS, BS2*, Tanushree Prasad, MA3*, Akshat M Patel, BA4, Aimaz Afrough, MD5, Larry D. Anderson Jr., MD, PhD6, Stephen S. Chung, MD5, Robert H. Collins, M.D.7, Gurbakhash Kaur, MD5,8, Kiran A Kumar, MD, MBA9*, Yazan F. Madanat, MD7, Madhuri Vusirikala, MD10*, Farrukh T. Awan, MD5,7 and Praveen Ramakrishnan Geethakumari, MD, MS11

1Internal Medicine, UT Southwestern Medical Center, Dallas, TX
2Division of Hematologic Malignancies, UT Southwestern Medical Center, Dallas, TX
3Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas
4Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX
5Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
6Cellular Therapy and Hematologic Malignancies Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
7Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
8Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
9Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX
10Division of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX
11Division of Hematologic Malignancies and Stem Cell Transplantation, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX

Heather S. L. Jim, PhD1*, Aasha I. Hoogland, PhD2*, Jennifer M. Logue, MD, BS, BA3, Briana Aguilar4*, Xiaoyin Li, PhD5*, Julia Thornton Snider, PhD6*, Sally West Wade7*, Christine T Fu, PhD8*, Julio C. Chavez, MD9, Michael D. Jain, MD, PhD10, Aleksandr Lazaryan, MD, PhD, MPH11, Bijal D. Shah, MD12 and Frederick L. Locke, MD13

1Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center, Tampa, FL
2Department of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
3Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center & Research Institution, Tampa, FL
4Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL
5Moffitt Cancer Center, Tampa, FL
6Kite, a Gilead Company, Santa Monica, CA
7Kite Pharma, Salt Lake City, UT
8Kite Pharma, Santa Monica, CA
9Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
10Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
11Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H.Lee Moffitt Cancer Center and Research Institute, Tampa, FL
12Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
13Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Krish Patel, MD1, Jakub Svoboda, MD2, Bijal D. Shah, MD3, Bruce D. Cheson, MD4, Georges Azzi, MD5*, Kashyap Patel, MD6*, Andrew J Cowan, MD7, Lori Muffly, MD8, Heidi Simmons, PhD9, Mark Schliekelman, PhD9* and Jessica Leonard, MD10

1Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle
2Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
3Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
4Lymphoma Research Foundation, New York
5Sylvester Cancer Center, Miami, FL
6Carolina Blood and Cancer Care Associates, Rock Hill, SC
7Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
8Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
9Adaptive Biotechnologies, Seattle, WA
10Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR

Snegha Ananth, MBBS1, Supreet Kaur, MD2, Alaq Al-Abayechi, MD1*, Jean Pierre Blaize, MD3, Lauren Diaz Boyle, DO4*, Lakene Raissa Djoufack Djoumessi, MD5, Manuel Espinoza Gutarra, MD6*, Kathleen Franklin, RN1*, Lindsey Lu, PharmD1*, Kana Tai Lucero1*, Phillip Nazarewicz, BS1*, Abhishek Pandya, DO7,8, Gabriel Roman Souza, MD8, Michael M. Song, MD, PhD, PharmD9, Brian Warnecke, DO10*, Jennifer Whitehead, MS1*, Madison H. Williams, MD11, Ryan A. Williams, MD11, Michael Mader, MS1* and Zohra Nooruddin, MD1

1South Texas Veterans Health Care System, San Antonio, TX
2UT Health Cancer Center, University of Texas Health Science Center at San Antonio, San Antonio
3Augusta Oncology, Augusta, Georgia
4Mays Cancer Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX
5National Institute of Health, Bethesda, MD
6O'neal Comprehensive Cancer Center, Birmingham, AL
7University of Texas Health Science Center at San Antonio, San Antonio, TX
8University of Texas Health San Antonio MD Anderson Cancer Center, San Antonio, TX
9Baylor College of Medicine, Houston, TX
10University of California, Irvine, Irvine, CA
11University of Texas MD Anderson Cancer Center, Houston, TX

Emmanuel Bachy, MD, PhD1*, Gandhi Laurent Damaj, MD, PhD2*, Qiufei Ma3*, Christian Hampp3*, James Harnett3*, Rachel E. Sobel3*, Jessica J. Jalbert, PhD3*, Ruben G.W. Quek3*, Wenhui Wei, PhD3*, Ning Wu3*, Vera Mastey3*, Joy Wang3*, Anit Bajwa3*, Benedikt Maissenhaelter4*, Chantal van Gils5*, Shivani Aggarwal6*, Aafia Chaudhry, MD, MBA, MS3*, Hesham Mohamed, MD3*, Srikanth R. Ambati, MBBS, MD3* and Catherine Thieblemont, MD, PhD7

1Hospices Civils de Lyon and Université Claude Bernard Lyon 1, Lyon, France
2Institut d'Hematologie de Basse-Normandie, CHU Cote de Nacre, Université de Normandie, Caen, France
3Regeneron Pharmaceuticals, Inc., Tarrytown, NY
4IQVIA, Munich, Germany
5IQVIA, Rotterdam, Netherlands
6IQVIA, Los Angeles, CA
7Université de Paris, Assistance Publique – Hôpitaux de Paris, Hopital Saint-Louis, Hemato-Oncologie, Paris, France

Brian J Scott, MD1*, Tracy Murray, NP2*, Gayle K Deutsch, PhD, ABPP2*, Sheila Lahijani, MD3*, Matthew J Frank, MD, PhD4 and Michelle Monje, MD, PHD5*

1Department of Neurology, Neuro-Immuno-Oncology, Stanford University, San Francisco, CA
2Stanford University, Palo Alto, CA
3Division of Psychiatry and Behavioral Sciences, Stanford University Hospital, Stanford, CA
4Center for Cancer Cell Therapy, Stanford University School of Medicine, Palo Alto, CA
5Stanford University School of Medicine, Palo Alto, CA

Aishwarya Sannareddy, MBBS1*, Heather Reves, MS, BS2*, Kefyalew Jaleta, MT (ASCP)3*, Ramyakumari .Ramiahsankarasubramanian, MBBS3*, Hetalkumari Patel, PharmD, BCOP4*, Madhusudhanan Narasimhan, PhD5*, Larry D. Anderson Jr., MD, PhD6, Aimaz Afrough, MD7, Stephen S. Chung, MD8, Robert H. Collins, M.D.1, Gurbakhash Kaur, MD1*, Kiran A Kumar, MD, MBA9*, Yazan F. Madanat, MD1, Madhuri Vusirikala, MD10*, Farrukh T. Awan, MD11, Alagarraju Muthukumar, PhD12* and Praveen Ramakrishnan Geethakumari, MD, MS10

1Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX
2Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Fort Worth, TX
3UT Southwestern Medical Center, Dallas, TX
4Department of Pharmacy, UT Southwestern Medical Center, Dallas, TX
5UT Southwestern Medical Center, Dallas, Dallas, TX
6Myeloma, Waldenstrom’s and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
7Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern, dallas, TX
8Division of Hematology and Oncology, Department of Internal Medicine, Children's Research Institute, University of Texas Southwestern, Dallas, TX
9Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX
10Division of Hematologic Malignancies, UT Southwestern Medical Center, Dallas, TX
11Division of Hematology and Oncology, The Ohio State University, Dallas, TX
12Department of Pathology, UT Southwestern Medical Center, Dallas, TX

Faouzi Djebbari1*, Alexandros Rampotas1*, Grant Vallance1*, Fotios Panitsas2*, Nanda Basker3*, Gina Sangha4*, Beena Salhan5*, Farheen Karim6*, Firas Al-Kaisi, MD7*, Amy Gudger8*, Loretta Ngu9*, Matt Poynton10*, Ho Pui Jeff Lam11*, Lowri Morgan12*, Laura Yang13*, Jennifer Young14*, Mairi Walker15*, Ismini Tsagkaraki16*, Laura Anderson17*, Saleena Rani Chauhan18*, Rebecca Maddams19*, Richard Soutar20*, Margarita Triantafillou21*, Steve Prideaux22*, Abubaker Obeidalla23*, Ceri Bygrave24*, Supratik Basu25* and Karthik Ramasamy26

1Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
2Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
3University Hospital Southampton, Southampton, United Kingdom
4Milton Keynes Hospital, Milton Keynes, United Kingdom
5Birmingham Heartlands Hospital, Birmingham, ENG, United Kingdom
6The Royal Wolverhampton NHS Turst, Wolverhampton, United Kingdom
7Royal Derby Hospital, Derby, ENG, United Kingdom
8Queen Elizabeth Hospital, Birmingham, United Kingdom
9Royal Devon & Exeter NHS Foundation Trust, Exeter, United Kingdom
10Royal Berkshire Hospital, Reading, United Kingdom
11Guy's and St Thomas NHS Foundation Trust, London, ENG, United Kingdom
12University Hospital of Wales, Cardiff, United Kingdom
13University Hospitals Sussex NHS Foundation Trust, Worthing, United Kingdom
14Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
15University Hospital Crosshouse, Crosshouse, United Kingdom
16Stoke Mandeville Hospital, Aylesbury, United Kingdom
17Royal United Hospital Bath, Bath, GBR
18Worcestershire Acute Hospitals NHS Trust, Worcester, United Kingdom
19Poole Hospital, Poole, United Kingdom
20Beatson Oncology Centre, Glasgow, United Kingdom
21Manchester Royal Infirmary, Manchester, United Kingdom
22Great Western Hospital, Swindon, United Kingdom
23Wexham Park Hospital, Slough, United Kingdom
24Department of Haematology, University Hospital of Wales, Cardiff, United Kingdom
25The Royal Wolverhampton NHS Trust and University, West Midlands Research Consortium (WMRC), Wolverhampton, United Kingdom
26Department of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Zhengrui Xiao, MD1, Hieu Liem Le Nguyen1*, Daming Shao2* and Irina Murakhovskaya, MD3

1Department of Hematology-Oncology, Montefiore Medical Center, Bronx, NY
2Department of Internal Medicine, Jacobi Medical Center, Bronx, NY
3Division of Hematology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

Caroline LE Lan1*, Aurelien Belot2*, Camille Golfier, MD3*, Berenice Audin3*, Pierre Sesques, MD3*, Adeline Bernier, PhD2*, Violaine Safar, MD3*, Alexandra Marquet2*, Emmanuelle Ferrant, MD3*, Anne Lazareth, MD3*, Helene Lequeu, MD3*, Fadhela Bouafia, MD3*, Lionel Karlin3*, Dana Ghergus, MD3*, Alizee Maarek, MD3*, Guillaume Aussedat3*, Maryam Idlhaj3*, Gilles Salles, MD, PhD4, Fanny Cherblanc, PhD2*, Emmanuel Bachy, MD, PhD3* and Herve Ghesquieres, MD, PhD5*

1Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, LYON, France
2LYSARC, The Lymphoma Academic Research Organisation, Lyon Sud University Hospital, Pierre Benite, France
3Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre Benite, France
4Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Hematology, Lyon Sud University Hospital/Hospices Civils de Lyon, Pierre Benite, France

Rafael Fonseca1, Diana Tran2*, Emily Rosta2*, Alyshia Laidlaw2*, Manvir Rai2*, Joana Duran3* and Eric M. Ammann4*

1Division of Hematology/Oncology, Mayo Clinic Arizona, Phoenix, AZ
2EVERSANA, Burlington, ON, Canada
3Janssen Global Medical Affairs, Raritan, NJ
4Janssen Global Services, LLC, Market Access, Raritan, NJ

Jennifer S Harper1*, Alex Z. Fu1,2*, Dee Lin3*, Bingcao Wu3*, Nina Kim3*, Savanna Ledford3* and Sundar Jagannath4

1Real World Research, Janssen Scientific Affairs, LLC, Titusville, NJ
2Department of Oncology, Georgetown University Medical Center, Washington, DC
3Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA
4Icahn School of Medicine at Mount Sinai, New York, NY

Tondre T. Buck, MD1*, Taylor Salinardi, PhD2* and Megan S. Rice, ScD, MPH2*

1Center for Hematology/Oncology, Spartanburg Medical Center, Spartanburg
2Sanofi, Cambridge, MA

Aneeqa A Zafar1*, Chiung-Yu Huang, PhD2*, Mimi Lo, PharmD, BCPS, BCOP3*, Jen Knoche, BSN, RN1*, Shagun Arora, MD4, Alfred Chung, MD4, Sandy W. Wong, MD4, Jeffrey L. Wolf, MD4, Thomas Martin, MD4, Nina Shah, MD5 and Rahul Banerjee, MD1,6

1University of California San Francisco, San Francisco, CA
2Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA
3Department of Pharmaceutical Services, University of California San Francisco, San Francisco, CA
4Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
5Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA
6Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA

Christopher E. Jensen, MD1,2, Tzy-Mey Kuo, PhD, MPH3*, Matthew Leblanc, PhD, BSN, RN4*, Chris D Baggett, PhD3*, Xi Zhou3*, Katherine E Reeder-Hayes4,5* and Jennifer L Lund, PhD6*

1Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC
2Division of Hematology, University of North Carolina School of Medicine, Chapel Hill, NC
3Cancer Information & Population Health Resource, University of North Carolina at Chapel Hill, Chapel Hill, NC
4Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
5Division of Oncology, University of North Carolina School of Medicine, Chapel Hill, NC
6Department of Epidemiology, University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Chapel Hill, NC

Ghulam Rehman Mohyuddin, MD1, Rajshekhar Chakraborty, MD2, Gregory Calip, PhD3*, Mustafa S Ascha, PhD, MS4*, Xiaoliang Wang, PhD, MPH5*, Samuel Rubinstein, MD6*, Sascha A. Tuchman, MD, MHS7, Luciano J. Megala Costa, MD, PhD8, Benjamin Haaland9*, Smith Giri, MD, MHS10, Hira S Mian, MD11, Rafael Fonseca12 and Douglas W. Sborov, MD13

1Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, Salt Lake City, UT
2Department of Medicine, Columbia University Irving Medical Center, Thornwood, NY
3Flatiron Health Inc, New York, NY
4Flatiron Health, New York, NY
5Flatiron Health Inc., New York, NY
6Division of Hematology, University of North Carolina-Chapel Hill, Chapel Hill, NC
7Department of Medicine, Division of Hematology, The University of North Carolina at Chapel Hill, Chapel Hill, NC
8University of Alabama at Birmingham Hospital, Vestavia, AL
9University of Utah, Salt Lake City
10Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
11Department of Oncology, McMaster University, Hamilton, ON, Canada
12Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
13Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT

Laurent Garderet, MD, PhD1, Luuk Gras2*, Linda Koster3*, Anita D'Souza, MD, MS4, Noel Estrada-Merly5*, Parameswaran Hari, MD, MRCP6, Wael Saber, MD, MS5, Andrew J Cowan, MD7, Minako Iida, MD, PhD8*, Shinichiro Okamoto, MD, PhD9, Hiroyuki Takamatsu, MD, PhD10, Shohei Mizuno, MD, PhD11*, Koji Kawamura12*, Yoshihisa Kodera, MD13*, Nada Hamad, MBBS, BSc, MSc14, Bor-Sheng Ko, MD, PhD15*, Christopher Liam16, Kim Wah Ho, MBBS, MRCP17*, A Sim Goh18*, S Keat Tan18*, Alaa M. Elhaddad, MD19, Ali Bazarbachi, MD, PhD20, Qamar un Nisa Chaudhry21*, Rozan Alfar, MBBS22*, Mohamed-Amine Bekadja23*, Malek Benakli, MD, PhD24, Cristobal Augusto Frutos Ortiz, MD25*, Eloisa Riva, MD, MEd26, Sebastian Galeano, MD27, Francisca Bass, MD28*, Hira S Mian, MD29, Arleigh McCurdy, MD, BSc30, Feng Rong Wang31*, Daniel Neumann32*, Mickey Koh, MD, PhD33*, John A Snowden34, Stefan Schönland35*, Donal P. McLornan, MD, PhD36*, Patrick John Hayden, MD37, Anna Sureda38, Hildegard T. Greinix, MD39, Mahmoud Aljurf, MD40, Yoshiko Atsuta41* and Dietger Niederwieser, MD42

1Service Hematologie, Sorbonne Université, Hopital Pitié Salpêtière APHP, Paris, France
2EBMT Statistical Unit, Leiden, The Netherlands, Leiden, Netherlands
3EBMT Data Office, Leiden, Netherlands
4Department of medicine, medical college of Wisconsin, Milwaukee
5CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
6Medical College of Wisconsin, Milwaukee, WI
7Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
8Aichi Medical University School of Medicine, Nagakute-cho, Aichi, JPN
9Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
10​School of Entrepreneurial and Innovation Studies, Kanazawa University, Kanazawa, Japan
11Department of Hematology, Aichi Medical University School of Medicine, Nagakute, AIC, Japan
12Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, SAI, Japan
13Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagoya, Japan
14Department of Haematology, St Vincent's Hospital Sydney, Australia and St Vincent's Clinical School, Sydney, University of New South Wales, Sydney, NSW, Australia
15National Taiwan University Hospital, Taipei, Taiwan
16Hospital Ampang, Ampang, Selangor, Malaysia
17Department of Hematology, Ampang Hospital, Ampang, Malaysia
18Penang general hospital, Penang, Malaysia
19Department of Pediatric Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Cairo University, Cairo, Egypt
20American University of Beirut Dept. of Medicine, Beirut, Lebanon
21AFBMTC/NIBMT, Rawalpindi, Pakistan
22King Hussein cancer center, Amman, ON, Jordan
23Department of Hematology and Cell Therapy, EHU 1st Novembre 1954 Bir el Djir Usto, University Ahmed Benbella 1, Oran, Algeria
24Centre Pierre et Marie Curie (CPMC), Algiers, Algeria
25Hospital Central Del Instituto De Prevision Social, Asuncion, Paraguay
26Cátedra de Hematología, Hospital de Clínicas, Facultad de Medicina, Montevideo, Montevideo, Uruguay
27Hematology Department, British Hospital, Montevideo, Montevideo, Uruguay
28Hospital del Salvador, Santiago, Chile
29Department of Oncology, McMaster University, Hamilton, ON, Canada
30Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
31Peking University, Beijing, China
32IMISE, university of Leipzig, Leipzig, Germany
33Department of Haematology, St George's Hospital NHS Foundation Trust, London, United Kingdom
34BSBMTCT, Department of Haematology, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom
35Department of Internal Medicine V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany
36Department of Haematology, Kings's College Hospital, London, ENG, United Kingdom
37Department of Haematology, Trinity College Dublin, St. James's Hospital, Dublin 8, Leinster, Ireland
38Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Barcelona, Spain
39Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
40Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
41Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
42University of Leipzig, Leipzig, Germany

Mitchell R Smith, MD1, Julie Dodds, PhD2*, Hetal Shah, MEng3*, Zoe Drymoussi2*, David Kennard, MBA, PhD3* and Steven Labkoff, MD4*

1The Follicular Lymphoma Foundation, Washington, DC
2The Follicular Lymphoma Foundation, London, ENG, United Kingdom
3The Follicular Lymphoma Foundation, London, United Kingdom
4Quantori, Cambridge, MA

Ulf-Henrik Mellqvist1, Qian Cai2*, Laura L Hester3*, Michael Grövdal4*, Jakob Börsum5*, Iffat Rahman6*, Eric M. Ammann7* and Markus Hansson8*

1Sahlgrenska University Hospital, Boras, Sweden
2Janssen Pharmaceuticals, Horsham, PA
3Janssen Pharmaceuticals, Titusville, NJ
4Janssen Pharmaceuticals, Stockholm, Sweden
5SDS Life Science, Uppsala, Sweden
6SDS Life Science, Danderyd, Sweden
7Janssen Global Services, LLC, Market Access, Raritan, NJ
8Sahlgrenska Academy, Göteborg University and Sahlgrenska University Hospital, Skåne University Hospital, Lund, Sweden

Patrick Connor Johnson, MD1, Tejaswini Dhawale, MD2,3, Mitchell W. Lavoie3*, Kyle Karpinski, BS3*, Netana H. Markovitz, MD4*, Kathleen Hennessey3*, Matthew Frigault, MD, MS3 and Areej El-Jawahri, MD3

1Cancer Center, Massachusetts General Hospital, Boston, MA
2Harvard Medical School, Boston, MA
3Massachusetts General Hospital, Boston, MA
4Beth Israel Deaconess Medical Center, Boston, MA

Ephrem Sedeta, MD, MSc.1, Nosakhare Ilerhunmwuwa1*, Mustafa Wasifuddin, MD1*, Ifeanyi Uche, MBBS1*, Narek Hakobyan, MD1*, Jamal Perry, MD1*, Henry Aiwuyo, MD1*, Hesham Abowali, MD2* and Boris Avezbakiyev, MD2*

1Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
2Division of Hematology and Medical Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY

Austin L Brown, MPH, PhD1,2*, Heidi V Russell, MD, PhD3*, Abiodun Oluyomi, PhD4*, Michelle Fritsch, MSW1*, Kayla Foster, MD1,2*, Omar Shakeel, MD1,2, Shawki Lotfi Qasim, MD1,2*, Fatih Okcu, MD1,2* and Maria Monica Gramatges, MD, PhD5

1Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Houston, TX
2Department of Pediatrics, Baylor College of Medicine, Houston, TX
3School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX
4Epidemiology and Population Sciences, Baylor College of Medicine, Houston, TX
5Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, TX

Poorva Bindal, MD1, Pavania Elavalakanar, MSc, BSc1*, Caitlin A. Trottier, MD2*, Laura E. Dodge, ScD MPH1,3*, Emma K. Logan1*, David J. Sermer, MD1, Michael Leukam, MD, MS1, Matthew J Weinstock, MD1, Robin M. Joyce, MD1, Jessica Liegel, MD1, Jacalyn Rosenblatt, MD1, David Avigan, MD1, Carolyn D. Alonso, MD1* and Jon E. Arnason, MD1

1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
2Tufts Medical Center, Boston, MA
3Harvard T.H. Chan School of Public Health, Boston, MA

Tycel Phillips, MD1*, Junhua Yu, PhD2*, Rajesh Kamalakar, MS3*, Kalatu R. Davies, PhD3*, Alex Mutebi, PhD4*, Savreet Bains Chawla, MS4*, Donald Arnette, PhD3*, Syed Quadri, PharmD3* and Anthony Wang, PhD, MPH3*

1University of Michigan, Ann Arbor, MI
2AbbVie Inc., North Chicago, IL
3AbbVie, Inc., North Chicago, IL
4Genmab, Princeton, NJ

Dee Lin1*, Jordan Richardson2*, Nina Kim1*, Savanna Ledford1*, Josh Feldman2*, Paul Boyce2* and Bingcao Wu1*

1Real World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA
2Inspire Insights, Inspire, Arlington, VA

Anthony J Messina, MSc1,2, Rachel Byrd, MS3*, Keri McDonough, MA2*, Darcy R Flora, PhD3*, Sam Schneider, BS3*, Sara D Towne, PhD2*, Julie Prock, BA2*, Lynn Donald, BSc2*, Dan Platt, MD3* and Jane K Bentley, PhD2*

1Clinical Research and Leadership, George Washington University, Port St Lucie, FL
2Patient Voice Consortium, Syneos Health, Morrisville, NC
3Department of Research, GRYT Health, Rochester, NY

Nicole Watts, PharmD1*, Courtney Hebert, PharmD2*, Clare Ubersax, BS3*, Deanna Clark, MBA, MPH3*, Gayathri Ravi, MD4, Susan Bal, MD1, Purnima Singh, PhD, MSc5, Kelly N. Godby, MD6*, Donna Salzman, MD7, Luciano J. Megala Costa, MD, PhD1, Grant Williams, MD, MPH8*, Smita Bhatia, MD, MPH3 and Smith Giri, MD, MHS3

1University of Alabama at Birmingham, Birmingham, AL
2Pharmacy, University of Alabama at Birmingham, Birmingham, AL
3Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
4Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
5Children's of Alabama Hospital, Birmingham, AL
6Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham Hospital, Birmingham, AL
7Divison of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
8Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL

Sneha T Reddy, MD1*, Larry A Saltzman, MD1*, Louis J DeGennaro, PhD1, Gwen L Nichols, MD1, Janaela Scott1*, Jonathon W Senefeld, PhD2*, Patrick W Johnson3* and Lee M Greenberger, PhD4

1The Leukemia & Lymphoma Society, Rye Brook, NY
2Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN
3Mayo Clinic, Jacksonville, FL
4The Leukemia & Lymphoma Society, Montclair, NJ

Karen Sweiss, PharmD1, Craig C Hofmeister, MD2, John G. Quigley, MD, FRCP (C)3, Jaleel G. Sweis4*, Kaily Kurzweil, PharmD5*, Douglas W. Sborov, MD6, Lisa Sharp, PhD, BSN, MA7*, Gregory S Calip, PharmD, MPH, PhD7, Lucas Maahs, MD3, Ana Maria Avila, MD3, Chukwuemeka Uzoka, MD3, Elizabeth Ilo8*, Elliot Wolf8*, Damiano Rondelli, MD3 and Pritesh Patel3

1Department of Pharmacy Practice, University of Illinois at Chicago, Hinsdale, IL
2Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
3Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
4University of Jordan, Amman, Jordan
5Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL
6Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT
7Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago, Chicago, IL
8Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL

*signifies non-member of ASH